BK0046
0.00
+0.00
--
最高
0.00
最低
0.00
成交量
0.00
今开
0.00
昨收
0.00
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
0.00
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
鲁抗医药拟定增募资不超过12亿元
北京商报 · 10:40
鲁抗医药拟定增募资不超过12亿元
鲁抗医药（600789）12月20日主力资金净买入3.25亿元
证券之星 · 12-21 08:11
鲁抗医药（600789）12月20日主力资金净买入3.25亿元
鲁抗医药获融资买入1.44亿元，近三日累计买入2.08亿元
金融界 · 12-21 08:03
鲁抗医药获融资买入1.44亿元，近三日累计买入2.08亿元
对赌收购引发的纷争落幕：基蛋生物四千万收购股份，景川诊断摘牌
新京报 · 12-20 23:48
对赌收购引发的纷争落幕：基蛋生物四千万收购股份，景川诊断摘牌
长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准
智通财经 · 12-20 22:39
长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准
昭衍新药(06127)将向舒泰神集团提供涵盖非临床及临床试验阶段的全方位医药研发服务
智通财经 · 12-20 21:53
昭衍新药(06127)将向舒泰神集团提供涵盖非临床及临床试验阶段的全方位医药研发服务
一个月内3人辞职！天坛生物高层震荡，年内股价跌近20%
深圳商报 · 12-20 20:44
一个月内3人辞职！天坛生物高层震荡，年内股价跌近20%
12月20日透景生命发布公告，其股东减持12.09万股
证券之星 · 12-20 20:01
12月20日透景生命发布公告，其股东减持12.09万股
莱茵生物最新公告：取得金融机构股票回购贷款承诺函
证券之星 · 12-20 20:00
莱茵生物最新公告：取得金融机构股票回购贷款承诺函
鲁抗医药(600789.SH)拟向控股股东等定增募资不超12亿元
智通财经 · 12-20 19:48
鲁抗医药(600789.SH)拟向控股股东等定增募资不超12亿元
鲁抗医药：拟向华鲁集团等定增募资不超过12亿元
格隆汇 · 12-20 19:47
鲁抗医药：拟向华鲁集团等定增募资不超过12亿元
鲁抗医药：拟定增募资不超12亿元 用于生物农药等项目
美港电讯 · 12-20 19:44
鲁抗医药：拟定增募资不超12亿元 用于生物农药等项目
鲁抗医药：与关联方签订《商标使用许可协议》
格隆汇 · 12-20 19:43
鲁抗医药：与关联方签订《商标使用许可协议》
鲁抗医药将于1月16日召开股东大会，审议无需编制前次募集资金使用情况报告等议案
金融界 · 12-20 19:30
鲁抗医药将于1月16日召开股东大会，审议无需编制前次募集资金使用情况报告等议案
鲁抗医药最新公告：拟与华鲁集团续签《商标使用许可协议》
证券之星 · 12-20 19:30
鲁抗医药最新公告：拟与华鲁集团续签《商标使用许可协议》
鲁抗医药最新公告：拟定增募资不超过12亿元
证券之星 · 12-20 19:29
鲁抗医药最新公告：拟定增募资不超过12亿元
开能健康：12月17日进行路演，太平洋证券、国盛证券参与
证券之星 · 12-20 18:03
开能健康：12月17日进行路演，太平洋证券、国盛证券参与
安图生物12月20日主力资金净流出1140.17万元
金融界 · 12-20 17:55
安图生物12月20日主力资金净流出1140.17万元
美康生物(300439.SZ)取得多项医疗器械注册证
智通财经 · 12-20 17:43
美康生物(300439.SZ)取得多项医疗器械注册证
天坛生物：高管辞职公告
新浪财经-鹰眼工作室 · 12-20 17:20
天坛生物：高管辞职公告
加载更多
{"stockData":{"symbol":"BK0046","market":"CN","secType":"PLATE","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatusCode":0,"change":0,"open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"adr":0,"adjPreClose":0},"requestUrl":"/m/hq/s/BK0046","defaultTab":"news","newsList":[{"id":"2493296089","title":"鲁抗医药拟定增募资不超过12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493296089","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493296089?lang=zh_cn&edition=full","pubTime":"2024-12-22 10:40","pubTimestamp":1734835209,"startTime":"0","endTime":"0","summary":"北京商报讯(记者丁宁)12月21日，鲁抗医药(600789)发布公告称，公司计划向包括控股股东华鲁控股集团有限公司在内的不超过三十五名符合条件的投资者发行股票，募集资金总额不超过12亿元。公告显示，此次募资在扣除发行费用后拟用于高端制剂智能制造车间建设项目、生物农药基地建设项目、新药研发项目以及补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222104459ab8a89cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241222104459ab8a89cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600789","BK0046","BK0168","BK0239","BK0188"],"gpt_icon":0},{"id":"2493061124","title":"鲁抗医药（600789）12月20日主力资金净买入3.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493061124","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493061124?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:11","pubTimestamp":1734739907,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月20日收盘，鲁抗医药报收于9.41元，上涨10.06%，涨停，换手率14.33%，成交量128.82万手，成交额11.8亿元。12月20日的资金流向数据方面，主力资金净流入3.25亿元，占总成交额27.55%，游资资金净流出1.59亿元，占总成交额13.44%，散户资金净流出1.66亿元，占总成交额14.1%。融券方面，融券卖出1.6万股，融券偿还0.0股，融券余量2.55万股，融券余额24.0万元。鲁抗医药主营业务：主要从事医药产品的研发、生产和销售等业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122100010960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0168","BK0046","BK0239","600789"],"gpt_icon":0},{"id":"2493406208","title":"鲁抗医药获融资买入1.44亿元，近三日累计买入2.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493406208","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493406208?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:03","pubTimestamp":1734739394,"startTime":"0","endTime":"0","summary":"12月20日，沪深两融数据显示，鲁抗医药获融资买入额1.44亿元，居两市第93位，当日融资偿还额1.69亿元，净卖出2496.01万元。最近三个交易日，18日-20日，鲁抗医药分别获融资买入0.33亿元、0.31亿元、1.44亿元。融券方面，当日融券卖出1.60万股，净卖出1.60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221080731ab8848ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221080731ab8848ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600789","BK0046","BK0168","BK0239","BK0188"],"gpt_icon":0},{"id":"2493242339","title":"对赌收购引发的纷争落幕：基蛋生物四千万收购股份，景川诊断摘牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2493242339","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493242339?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:48","pubTimestamp":1734709724,"startTime":"0","endTime":"0","summary":"对赌条款引发股权收购纠纷最新判决结果显示，湖北省武汉市中级人民法院驳回上诉，维持原判。这场持久的股权收购纠纷案起于基蛋生物控股景川诊断。2020年7月，基蛋生物收购了马全新、胡淑君等21名股东合计持有的景川诊断54.96%的股份，转让总价款6391.03万元。8月7日，景川诊断宣布，因暴力闯入事件，暂停生产。基蛋生物2023财报被出具“非标意见”，景川诊断未能如期披露2023年度报告，其股票于5月6日起停牌，并于10月24日终止挂牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220235521a1fe4ce5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220235521a1fe4ce5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603387","BK0046","BK0042"],"gpt_icon":0},{"id":"2492444532","title":"长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444532","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444532?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:39","pubTimestamp":1734705546,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司——长春百克生物科技股份公司(简称“百克生物”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，Ⅱ型单纯疱疹病毒mRNA疫苗的临床试验申请(预防由Ⅱ型单纯疱疹病毒感染导致的生殖器疱疹)获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0028","159646","000661","BK1141","03347","BK0057","BK0239","BK1576","BK0188","BK0075","BK1583"],"gpt_icon":0},{"id":"2492465314","title":"昭衍新药(06127)将向舒泰神集团提供涵盖非临床及临床试验阶段的全方位医药研发服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2492465314","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492465314?lang=zh_cn&edition=full","pubTime":"2024-12-20 21:53","pubTimestamp":1734702801,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，于2024年12月20日，本公司与舒泰神订立2025年舒泰神研发服务框架协议，期限为2025年1月1日至2025年12月31日。本公司须按2025年舒泰神研发服务框架协议向舒泰神集团提供涵盖非临床及临床试验阶段的全方位医药研发服务。由于与舒泰神集团的长期合作使我们能够进一步开拓医药合同研究组织服务市场并提高我们的品牌声誉，董事认为2025年舒泰神研发服务框架协议与本公司的业务及商业目标一致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","03347","BK0046","BK1141","BK1574","BK0239","BK0216","09939","603127","BK1515","BK1583","BK1576","06127","BK1161","300204","159938"],"gpt_icon":0},{"id":"2492451574","title":"一个月内3人辞职！天坛生物高层震荡，年内股价跌近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492451574","media":"深圳商报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492451574?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:44","pubTimestamp":1734698648,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端注意到，近一个月内，天坛生物已有3名高层人员辞职。更早之前，天坛生物总经理付道兴于今年7月退休离任。短期内，天坛生物高层人员频繁变动，引发市场关注。其中，第三季度，天坛生物营收同比下滑7.44%至12.32亿元；归母净利润增速明显放缓，同比微增1.57%至3.26亿元。此外，财报显示，天坛生物第三季度经营活动产生的现金流量净额同比锐减91.39%至9201.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220212247ab873e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220212247ab873e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0168","BK0185","BK0188","BK0082","600161","BK0239","BK0010","BK0046"],"gpt_icon":0},{"id":"2492412240","title":"12月20日透景生命发布公告，其股东减持12.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492412240","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492412240?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:01","pubTimestamp":1734696083,"startTime":"0","endTime":"0","summary":"证券之星消息，12月20日透景生命发布公告《透景生命:简式权益变动报告书》，其股东UBS AG于2024年12月19日合计减持12.09万股，占公司目前总股本的0.0741%，变动期间该股股价下跌0.26%，截止12月19日收盘报15.28元。股东增减持详情见下表：根据透景生命2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000038728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300642","BK0239","BK0046"],"gpt_icon":0},{"id":"2492341224","title":"莱茵生物最新公告：取得金融机构股票回购贷款承诺函","url":"https://stock-news.laohu8.com/highlight/detail?id=2492341224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492341224?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:00","pubTimestamp":1734696050,"startTime":"0","endTime":"0","summary":"莱茵生物公告，公司收到中信银行股份有限公司桂林分行出具的《贷款承诺函》，承诺贷款额度最高不超过6,000万元人民币，贷款期限为三年，专项用于回购上市公司股票。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000038694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002166","BK0168","BK0028","BK0174","BK0046"],"gpt_icon":0},{"id":"2492119684","title":"鲁抗医药(600789.SH)拟向控股股东等定增募资不超12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492119684","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492119684?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:48","pubTimestamp":1734695281,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鲁抗医药(600789.SH)发披露向特定对象发行A股股票预案，发行对象为包括公司控股股东华鲁集团在内的不超过三十五名符合中国证监会、上交所规定条件的投资者，发行股票数量不超过2.7亿股(含本数)。其中，华鲁集团拟认购鲁抗医药本次向特定对象发行股票数量的23.81%，即认购股票数量不超过6420.14万股(含本数)。本次向特定对象发行股票的募集资金总额不超过12亿元(含本数)，扣除发行费用后拟用：高端制剂智能制造车间建设项目、生物农药基地建设项目、新药研发项目、补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600789","BK0239","BK0188","BK0046","BK0168"],"gpt_icon":0},{"id":"2492414828","title":"鲁抗医药：拟向华鲁集团等定增募资不超过12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414828","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414828?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:47","pubTimestamp":1734695230,"startTime":"0","endTime":"0","summary":"其中，华鲁集团拟按照本次发行前华鲁集团、华鲁投资持有公司的股份比例进行同比例认购本次向特定对象发行的股票，按照截至2024年9月30日的公司股本情况测算，华鲁集团拟认购鲁抗医药本次向特定对象发行股票数量的23.81%，即认购股票数量不超过64,201,417股（含本数）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220195212ab86f8f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220195212ab86f8f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600789","BK0168","BK0239","BK0046"],"gpt_icon":0},{"id":"2492411329","title":"鲁抗医药：拟定增募资不超12亿元 用于生物农药等项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2492411329","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492411329?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:44","pubTimestamp":1734695092,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","BK0168","600789","BK0046","BK0188"],"gpt_icon":0},{"id":"2492414841","title":"鲁抗医药：与关联方签订《商标使用许可协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414841","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414841?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:43","pubTimestamp":1734695021,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨鲁抗医药公布，“鲁抗”注册商标及相关产品商标为华鲁集团所有。2022年4月，公司与华鲁集团就华鲁集团持有的“鲁抗”注册商标及相关产品商标达成商标使用许可协议，对“鲁抗”注册商标及相关产品商标按照每年760万元向公司收取商标使用费，协议有效期三年。鉴于上述商标许可协议即将期满，经公司与华鲁集团协商，拟续签商标使用许可协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220195208a1fdb978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220195208a1fdb978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0168","600789","BK0188","BK0046","BK0239"],"gpt_icon":0},{"id":"2492148444","title":"鲁抗医药将于1月16日召开股东大会，审议无需编制前次募集资金使用情况报告等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2492148444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492148444?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:30","pubTimestamp":1734694233,"startTime":"0","endTime":"0","summary":"金融界12月20日消息，鲁抗医药发布公告，将于2025年1月16日召开第1次临时股东大会，网络投票同日进行。股权登记日为1月9日，当日收市后持有鲁抗医药股票的投资者可以参与投票。会议地点：山东鲁抗医药股份有限公司高新园区A1115会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220193321ab86eb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220193321ab86eb1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600789","BK0046","BK0168","BK0239","BK0188"],"gpt_icon":0},{"id":"2492219419","title":"鲁抗医药最新公告：拟与华鲁集团续签《商标使用许可协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2492219419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492219419?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:30","pubTimestamp":1734694225,"startTime":"0","endTime":"0","summary":"鲁抗医药公告，公司拟与控股股东华鲁集团续签《商标使用许可协议》。根据协议，公司将继续使用“鲁抗”注册商标及相关产品商标，使用年费为人民币760万元，协议有效期为2025年全年。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000036867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600789","BK0188","BK0168","BK0239","BK0046"],"gpt_icon":0},{"id":"2492419248","title":"鲁抗医药最新公告：拟定增募资不超过12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492419248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492419248?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:29","pubTimestamp":1734694190,"startTime":"0","endTime":"0","summary":"鲁抗医药公告，公司计划向包括控股股东华鲁控股集团有限公司在内的不超过三十五名符合条件的投资者发行股票，募集资金总额不超过12亿元，扣除发行费用后用于高端制剂智能制造车间建设项目、生物农药基地建设项目、新药研发项目以及补充流动资金。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000036866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600789","BK0188","BK0168","BK0046"],"gpt_icon":0},{"id":"2492901564","title":"开能健康：12月17日进行路演，太平洋证券、国盛证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2492901564","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492901564?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:03","pubTimestamp":1734688992,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月20日开能健康发布公告称公司于2024年12月17日进行路演，太平洋证券、国盛证券参与。开能健康2024年三季报显示，公司主营收入12.54亿元，同比上升1.0%；归母净利润8416.5万元，同比下降34.92%；扣非净利润8137.75万元，同比下降17.95%；其中2024年第三季度，公司单季度主营收入4.25亿元，同比下降4.74%；单季度归母净利润2713.32万元，同比下降64.08%；单季度扣非净利润2726.06万元，同比下降43.39%；负债率55.73%，投资收益-1476.52万元，财务费用1126.53万元，毛利率40.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000032227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0150","BK0020","300272","BK0077","BK0183","BK0012","BK0028","BK0188","601099","BK0042","BK0201","BK0224","BK0276","BK0135","161027","BK0046"],"gpt_icon":0},{"id":"2492415172","title":"安图生物12月20日主力资金净流出1140.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415172","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492415172?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:55","pubTimestamp":1734688549,"startTime":"0","endTime":"0","summary":"资金流向方面，今日主力资金净流出1140.17万元，占比成交额6.76%。安图生物最新一期业绩显示，截至2024三季报，公司营业总收入33.80亿元、同比增长4.24%，归属净利润9.56亿元，同比增长6.13%，扣非净利润9.30亿元，同比增长6.69%，流动比率2.569、速动比率2.179、资产负债率25.49%。通过天眼查大数据分析，郑州安图生物工程股份有限公司共对外投资了19家企业，参与招投标项目861次，知识产权方面有商标信息80条，专利信息555条，此外企业还拥有行政许可1360个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220181440a1fd741a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220181440a1fd741a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2492492187","title":"美康生物(300439.SZ)取得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492492187","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492492187?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:43","pubTimestamp":1734687832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美康生物(300439.SZ)公告，公司近日取得了由国家药品监督管理局和浙江省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，相关产品名称分别为：抗脱氧核糖核酸酶B检测试剂盒(胶乳免疫比浊法)、凝血多项质控品、凝血酶原时间检测试剂盒(凝固法)、纤维蛋白溶酶原检测试剂盒(发色底物法)、异常凝血酶原(PIVKA-Ⅱ)检测试剂盒(化学发光免疫分析法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1574","300439","BK0042","BK1100","BK0239","BK1583","BK1222","09997","BK0046","159883"],"gpt_icon":0},{"id":"2492494058","title":"天坛生物：高管辞职公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2492494058","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492494058?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:20","pubTimestamp":1734686400,"startTime":"0","endTime":"0","summary":"北京天坛生物制品股份有限公司高管辞职公告本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。北京天坛生物制品股份有限公司董事会收到公司副总经理刘亚娜女士的书面辞职申请。刘亚娜女士由于工作调整原因，提出辞去公司副总经理职务，辞去上述职务后刘亚娜女士将继续担任公司党委书记、董事职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-20/doc-ineacaap3029700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0010","BK0185","BK0046","600161","BK0188","BK0239","BK0028","BK0168","BK0082"],"gpt_icon":0}],"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"undefined(BK0046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供undefined(BK0046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":",BK0046,股票,股票老虎,股票老虎国际,行情,股票行情,股价,股市,股票价格,股票交易,股票购买,股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"undefined(BK0046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供undefined(BK0046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}